GRANTS

134 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

BRAIN: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01)

Sponsor: National Institute of Biomedical Imaging and Bioengineering; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; Office of Behavioral and Social Science Research; Office of Research on Women's Health

Award: The NIH BRAIN initiative intends to fund an estimate of 15 to 20 awards, corresponding to a total of up to $6 million for FY2016.

Due Date: October 21, 2015

Clinical and Translational Science Award (U54)

Sponsor: National Center for Advancing Translational Sciences

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Multiple dates, see announcement.

NINDS Research Program Award (R35)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: NINDS intends to commit up to $20 million in FY 2016 to fund up to 30 awards.

Due Date: January 07, 2016

Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science (R44)

Sponsor: National Institute of Biomedical Imaging and Bioengineering, National Center for Advancing Translational Sciences, National Center for Complementary and Integrative Health ,National Cancer Institute, National Human Genome Research Institute, National Institute on Aging, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Drug Abuse, National Institute of Environmental Health Sciences, National Institute of Neurological Disorders and Stroke, Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($1,500,000 for Phase II). As written in the statute and under appropriate circumstances, NIH can apply for a waiver from SBA to issue an award exceeding $1,500,000 for Phase II, if this cap will interfere with NIH‘s ability to meet its mission. Award waivers from the SBA are not guaranteed and may delay the release of funds. Applicants are strongly encouraged to contact NIH program officials prior to submitting any application in excess of the guidelines. In all cases, applicants should propose a budget that is reasonable and appropriate for completion of the research project.

Due Date: Multiple dates, see announcement.

Opportunities for Collaborative Research at the NIH Clinical Center (U01)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. The maximum amount available per application is $500,000 direct costs (exclusive of any contract/consortium F&A) per year; which includes clinical center costs and intramural investigators' costs attributed to the proposed research project.

Due Date: Multiple; see announcement

NINDS Exploratory Clinical Trials for Small Business (R44)

Sponsor: National Institutes of Health, National Institute of Neurological Disorders and Stroke

Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase 1 awards and $1,000,000 for Phase 2 awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase 1 and $1,500,000 for Phase 2).

Due Date: Multiple dates, see announcement.

NINDS Exploratory Clinical Trials for Small Business (R42)

Sponsor: National Institutes of Health, National Institute of Neurological Disorders and Stroke

Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase 1 awards and $1,000,000 for Phase 2 awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase 1 and $1,500,000 for Phase 2).

Due Date: Multiple dates, see announcement.

Current Filters

No filters selected

Filter By